SiCl 4 mediated one-pot synthesis of novel spirobibenzopyrans as potent anticancer agents

Authors:

Abstract
This study is the first report on the anticancer activity of spirobibenzopyrans, an unexplored class of therapeutic agents. The synthesized spirobibenzopyrans were tested for anticancer activity across the NCI-60 cell-line panel. The in vitro and in silico results of the spirobibenzopyrans showed tremendous drug likeness scores as potential anticancer agents.

This publication has 17 references indexed in Scilit: